Nutrition Business Journal

Atrium Innovations in play?

Permira, the Fonds, the Caisse offer $24 per share for leading supplements rollup

Over the weekend, Atrium Innovations announced its pending acquisition by a consortium of investors led by Permira, a European private-equity bank with C$30 billion in assets under management. The deal values Atrium at C$24 per share, a premium of 23% over the previous day's trading price. Post-close, Permira would own 75% of the nutrition and health products company, with two long-term minority shareholders--the Fond and the Caisse--splittin

Register to view the full article

Register for and gain access to premium content including the Natural Products Industry Market Overview, webinars, and white papers.

Already a member? .

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.